RxDoctor Payments Data

Stacey Lombardo, APRN

Adult Health · Danbury, CTNPI 1891245916

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.1% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,341, more than ten times the $246 reported in 2022. Among adult health clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,298in general payments, 2019–2025

Across 149 payments — averaging $35.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$959
  • LEO Pharma Inc.$684
  • Johnson & Johnson$567
  • AbbVie$554
  • Incyte Corporation$443
  • Boston Scientific$246
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$5,19898%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,298 in reported general payments places this provider in the 90th percentile of 418 adult health providers in Connecticut.

See all adult health providers in Connecticut

Medicare billing

Part B allowed, 2024
$32,290
Medicare patients
217
Services billed
437

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide30$32,154
JanuviaSitagliptin Phosphate17$21,333
JanumetSitagliptin Phos/Metformin Hcl13$12,093
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$3,162
Atorvastatin Calcium222$2,635
Amlodipine Besylate153$1,435
Albuterol Sulfate HfaAlbuterol Sulfate46$1,183
Levothyroxine Sodium109$1,094
Gabapentin38$911
Losartan Potassium94$878
Rosuvastatin Calcium69$784
Lisinopril99$757
Metformin Hcl76$667
Simvastatin52$660
Clobetasol Propionate11$603

Paid to pharmacies, not to this prescriber.

Other adult health in Danbury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →